ATCA is recruiting a senior advisory board member: an accomplished executive, physician leader, healthcare innovator, or strategic operator with a track record in healthcare transformation, clinical innovation, precision medicine, or scalable care delivery. This is a board-level engagement for a leader who wants to help shape one of the most important emerging platforms in modern medicine: a data-driven, innovation-led model for Alzheimer’s and dementia care.
About Alzheimer’s Treatment Centers of America (ATCA)
Alzheimer’s Treatment Centers of America is building the national infrastructure for precision-based Alzheimer’s and dementia care. The model integrates proprietary AI, personalized treatment protocols, and a replicable specialty clinic platform purpose-built to identify the underlying drivers of neurodegeneration and deliver individualized interventions that measurably slow progression.
ATCA’s flagship clinic in Palm Beach Gardens/Jupiter is fully operational, payer-integrated, and running at capacity with appointments booked months out. Additional clinics are in active development. The company is executing a disciplined national expansion backed by a multidisciplinary team of healthcare executives, neuroscientists, AI engineers, and clinical specialists.
Why Now
Proven Demand:
The flagship clinic, positioned in a high-visibility corridor adjacent to Cleveland Clinic, reached full capacity rapidly, validating the market thesis for proactive Alzheimer’s and cognitive care.
Payer Alignment:
Services are reimbursed by Medicare, Medicare Advantage, and major commercial insurers, reducing adoption friction and supporting accelerated revenue growth.
Demonstrated Outcomes:
In a study using ATCA’s AI-driven protocol, 75% of patients with mild cognitive impairment showed no further cognitive decline, creating a meaningful clinical and strategic differentiator.
Market Scale:
ATCA is positioned within a $355B U.S. Alzheimer’s market and a $1.5T global opportunity, with embedded research infrastructure that can generate real-world evidence, partnerships, and additional revenue streams.
Financial Model:
The clinic platform is engineered to target strong EBITDA margins through optimized staffing, a high-acuity service mix, and reimbursement dynamics designed for repeatable multi-market expansion.
Key Achievements
Proprietary AI Precision Engine:
ATCA has built and deployed a defensible AI-driven precision medicine platform that optimizes Alzheimer’s treatment at the individual patient level, creating strong clinical differentiation and long-term data network effects.
High-Margin, Replicable Clinic Model:
ATCA has developed a scalable specialty clinic platform designed for repeatable expansion, supported by strong unit economics and multi-market rollout potential.
Massive, Underserved Market Opportunity:
The company is positioned to capture share in one of the largest and fastest-growing unmet-need categories in healthcare.
Embedded Innovation Infrastructure:
Each clinic is designed not only to deliver patient care, but also to generate data, insights, research opportunities, and long-term strategic value that strengthen the platform over time.
Responsibilities Include
As a senior advisory board member, your contribution centers on four domains:
Innovation Strategy:
Advise on the development, positioning, and expansion of ATCA’s Alzheimer’s innovation platform, including differentiated care models, precision treatment frameworks, and strategic growth priorities.
Scalable Care Model Development:
Guide the standardization and replication of Alzheimer’s and cognitive care programs across markets, including care pathway design, interdisciplinary operating models, and systems that preserve rigor at scale.
Clinical, Market & Strategic Differentiation:
Provide guidance on outcomes strategy, payer alignment, competitive positioning, value proposition development, and the responsible integration of innovation into clinical practice.
Governance & Responsible Scaling:
Advise on digital health integration, AI-enabled decision support, strategic partnerships, and the governance infrastructure needed to scale Alzheimer’s innovation credibly and responsibly.
Why Join Us?
Board-Level Leverage:
Bring strategic influence to a high-impact platform without day-to-day operational demands.
Early-Stage Upside:
Select roles include equity participation aligned with long-term contribution, with optional access to growth financing initiatives.